��������

Gabrielle KORNMANN is a seasoned professional in pharmacovigilance and drug safety, currently serving as the Drug Safety and Pharmacovigilance Leader at the Global Antibiotic R&D Partnership (GARDP) since September 2020. Previously, KORNMANN held various key positions at GeNeuro SA, including Pharmacovigilance Director and Medical Affairs and Alliance Director, from January 2015 to July 2020. A temporary role as a Pharmacist at HUG - Hôpitaux Universitaires de Genève involved preparing and reporting individual case safety reports to Swissmedic. Prior experiences include a sailing trip coupled with part-time teaching and a position as Senior Safety Scientist at United BioSource Corporation. KORNMANN's extensive career in the pharmaceutical industry also includes over a decade at Merck Serono, where leadership roles in medical safety evaluation were held, as well as a foundational period as a Clinical Data Analyst at the University of Geneva alongside a PhD in Pharmacology. KORNMANN earned a Federal Pharmacy Diploma in Pharmacy from the University of Geneva.